Table 2 Summary Statistics – Medications
Variables | Not Readmitted | Readmitted |
|---|---|---|
mean (sd) | mean (sd) | |
Medication Administration Route/Type Count | ||
Inhalation | 0.37 (0.99) | 0.30 (0.91) |
Injectable | 2.14 (4.08) | 2.61 (4.91) |
Intramuscular | 0.15 (0.44) | 0.09 (0.41) |
Intravenous | 1.55 (3.18) | 2.16 (4.31) |
Ophthalmic | 0.13 (0.44) | 0.08 (0.41) |
Oral | 2.01 (3.27) | 2.75 (4.42) |
Rectal | 0.14 (0.44) | 0.11 (0.42) |
Topical | 0.31 (0.73) | 0.38 (0.89) |
Generic Medications | ||
Acetaminophen | 0.43 (0.71) | 0.39 (0.71) |
Acetaminophen hydrocodone | 0.05 (0.25) | 0.04 (0.21) |
Albuterol | 0.18 (0.54) | 0.13 (0.43) |
Cefazoline | 0.10 (0.38) | 0.08 (0.33) |
Ceftriaxone | 0.07 (0.31) | 0.07 (0.29) |
Dexamethasone | 0.08 (0.34) | 0.11 (0.43) |
Diphenhydramine | 0.11 (0.39) | 0.22 (0.53) |
Docusate | 0.04 (0.23) | 0.06 (0.26) |
Epinephrine | 0.05 (0.25) | 0.07 (0.30) |
Erythromycin ophthalmic | 0.07 (0.25) | 0.02 (0.12) |
Fentanyl | 0.16 (0.45) | 0.14 (0.45) |
Glycopyrrolate | 0.05 (0.24) | 0.05 (0.24) |
Heparin | 0.17 (0.54) | 0.33 (0.74) |
Hepatitis B vaccine | 0.06 (0.24) | 0.01 (0.12) |
Ibuprofen | 0.14 (0.39) | 0.09 (0.32) |
Ketorolac | 0.07 (0.29) | 0.05 (0.24) |
Lidocaine | 0.08 (0.31) | 0.07 (0.30) |
Lidocaine topical | 0.11 (0.33) | 0.14 (0.36) |
Lorazepam | 0.07 (0.31) | 0.14 (0.42) |
LVP solution | 0.48 (1.01) | 0.72 (1.40) |
LVP solution with potassium | 0.20 (0.45) | 0.21 (0.48) |
Midazolam | 0.12 (0.40) | 0.12 (0.40) |
Morphine | 0.20 (0.56) | 0.19 (0.58) |
Ondansetron | 0.20 (0.48) | 0.29 (0.59) |
Oxycodone | 0.05 (0.24) | 0.06 (0.28) |
Phytonadione | 0.08 (0.27) | 0.03 (0.18) |
Polyethylene glycol 3350 | 0.05 (0.23) | 0.10 (0.30) |
Potassium chloride | 0.07 (0.32) | 0.12 (0.43) |
Propofol | 0.10 (0.35) | 0.10 (0.36) |
Ranitidine | 0.07 (0.30) | 0.11 (0.37) |
Rocuronium | 0.05 (0.23) | 0.04 (0.22) |
Sodium chloride | 0.19 (0.54) | 0.25 (0.65) |